October 28, 1996
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
RE: Rule 24f-2 Notice for
EV Traditional Worldwide Health Sciences Fund, Inc.
(formally Medical Research Investment Fund, Inc.)
1933 Act File No. 2-95103
1940 Act File No. 811-4196
In accordance with the provisions of Rule 24f-2 under the Investment
Company Act of 1940, EV Traditional Worldwide Health Sciences Fund, Inc.
(formally Medical Research Investment Fund, Inc.) hereby files its Rule 24f-2
Notice for the fiscal year ended August 31, 1996 ("Fiscal Year").
No shares of the Trust which have been registered under the Securities Act
of 1933 (other than pursuant to Rule 24f-2) remained unsold at the beginning of
the Fiscal Year.
No shares of the Trust were registered during the Fiscal Year pursuant to
Rule 24e-2.
5,439,762 shares of the Trust, with an aggregate sales price of
$68,676,368, were sold during the Fiscal Year in reliance upon the Declaration
of the Trust pursuant to Rule 24f-2 which registered an indefinite amount of
securities. Attached to this Rule 24f-2 Notice, and made part hereof, is an
opinion of counsel indicating that the securities, the registration of which
the Notice makes definite in number, were legally issued, fully paid, and non-
assessable by the Trust.
236,367 shares of the Trust, with an aggregate sales price of $2,491,303,
were issued during the Fiscal Year in connection with the Trust's dividend
reinvestment plan.
For the Fiscal Year, the Trust sold an aggregate of 5,676,129 shares,
including those issued pursuant to its dividend reinvestment plan, with an
aggregate sales price of $71,167,671.
In accordance with subsection (c) of Rule 24f-2, $9,565.05 has been wired
to the SEC Account at Mellon Bank, which represents the registration fee. Such
fee is based upon the actual aggregate sale price for which such securities
were sold during the Fiscal Year, including dividend reinvestments, reduced by
the actual aggregate redemption price of the shares redeemed by the Trust
during the Fiscal Year.
<PAGE>
Rule 24f-2 Notice for Page 2
EV Traditional Worldwide Health Sciences Fund, Inc.
(formally Medical Research Investment Fund, Inc.)
1933 Act File No. 2-95103
1940 Act File no. 811-4196
Aggregate Sale Price for Shares
Sold During Fiscal Year Pursuant to
Rule 24f-2 $ 68,676,368
Aggregate Price of Shares Issued
During Fiscal Year In Connection
with Dividend Reinvestment Plan 2,491,303
Aggregate Price of Shares Sold $ 71,167,671
Reduced by the Difference Between
(1) Aggregate Redemption Price of
Shares Redeemed During the
Fiscal Period 39,602,995
and
(2) Aggregate Redemption Price of
Redeemed Shares Previously
Applied by Trust Pursuant to
Rule 24e-2(a) in Filings Made
Pursuant to Section 24(e)(1) of
Investment Company Act of 1940 0
Equals $ 31,564,676
Any questions regarding the matter should by addressed to Jim Thebado, Eaton
Vance Management, 24 Federal Street, Boston, Massachusetts 02110.
Sincerely,
James L. O'Connor
Treasurer
<PAGE>
October 28, 1996
OPINION OF COUNSEL
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
RE: Rule 24f-2 Notice for
EV Traditional Worldwide Health Sciences Fund, Inc.
(formally Medical Research Investment Fund, Inc.)
1933 Act File No. 2-95103
1940 Act File No. 811-4196
Gentlemen:
By the filing of the captioned Notice pursuant to Rule 24f-2 under the
Investment Company Act of 1940, as amended, the Trust made definite the
registration under the Securities Act of 1933 of 5,676,129 shares sold,
including those pursuant to its dividend reinvestment plan, in reliance upon
said Rule 24f-2 during the fiscal year ended August 31, 1996.
It is the opinion of the undersigned that such shares were legally issued,
fully paid and nonassessable.
Sincerely,
H. Day Brigham, Jr.
Vice President and
Chairman of the Executive Committee
Member of Massachusetts and New York
Bars
